M health care spinoff Solventum is selling its purification business to Thermo Fisher Scientific for $4.1 billion in cash to ...
Companies confirm deal details. Thermo Fisher Scientific (NYSE:TMO) confirmed that it agreed to purchase Solventum's ...
6d
GlobalData on MSNThermo Fisher strikes $4.1bn deal for Solventum’s purification and filtration unitGlobalData analyst Dr Andrew S Thompson expects the deal to prompt a "shuffle" in Thermo Fisher’s life sciences unit.
The addition of Solventum’s business provides a strategic fit with Thermo Fisher and will create value for customers, ...
Thermo Fisher Scientific agreed to pay about $4.1 billion in cash to acquire Solventum’s purification and filtration business ...
Solventum (NYSE: SOLV) today announced it has entered into a definitive agreement to sell its Purification & Filtration1 ...
Waltham-based Thermo is buying the business from Solventum, a Minnesota-based company that spun off from manufacturing ...
Solventum surpassed fourth-quarter revenue and earnings expectations while facing challenges in segments and regulatory ...
Solventum Corp., 3M’s medtech spinoff, has sold its purification and filtration business to Massachussetts-based Thermo ...
Well, welcome to the 45th Annual TD Cowen Healthcare Conference. I'm Dan Brennan, follow Tools and Diagnostics. Really pleased to be joined on stage here with Marc Casper, Chairman and President of ...
Contract drug manufacturer Thermo Fisher Scientific said on Tuesday it will buy Solventum's purification and filtration ...
Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, today announced that the company has entered into a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results